China Shineway Pharmaceutical Group Limited
OTC: CSWYY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zhenjiang Li
- Employees
- 3,220
- Headquarters
- Shijiazhuang, China
- IPO year
- 2012
- Market cap
- $36.4M
- Website
- https://www.shineway.com
Loading CSWYY…
Loading profile data…Frequently asked questions about CSWYY
What does China Shineway Pharmaceutical Group Limited (CSWYY) do?
As an investment holding company, China Shineway Pharmaceutical Group Limited primarily focuses on the research, development, production, and commercialization of traditional Chinese medicines across mainland China and Hong Kong. Its product portfolio encompasses contemporary Chinese medicines delivered as soft capsules, granules, and injectable...
Where does CSWYY trade?
China Shineway Pharmaceutical Group Limited (CSWYY) trades on the Other OTC.
What sector is CSWYY in?
China Shineway Pharmaceutical Group Limited (CSWYY) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of China Shineway Pharmaceutical Group Limited?
Zhenjiang Li is the chief executive officer of China Shineway Pharmaceutical Group Limited (CSWYY).
Where is China Shineway Pharmaceutical Group Limited headquartered?
China Shineway Pharmaceutical Group Limited is headquartered in China.
Does CSWYY pay a dividend?
Yes — China Shineway Pharmaceutical Group Limited (CSWYY) paid a trailing twelve-month dividend of USD 1.42 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CSWYY go public?
China Shineway Pharmaceutical Group Limited (CSWYY) completed its initial public offering in 2012.
Is CSWYY an ADR?
Yes — CSWYY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. China Shineway Pharmaceutical Group Limited reporting and dividends follow the underlying issuer.